1. Haertle, Larissa, Barrio, Santiago, Munawar, Umair, Rasche, Leo, Kortüm, K Martin. . Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma. In Clinical cancer research : an official journal of the American Association for Cancer Research, 29, 279-288. doi:10.1158/1078-0432.CCR-22-1161. https://pubmed.ncbi.nlm.nih.gov/36282272/
2. Shi, Hui-Zhong, Wang, Ming-Wei, Huang, Yu-Song, Li, Ling, Wan, Li-Ping. 2024. A telomere-related gene risk model for predicting prognosis and treatment response in acute myeloid leukemia. In Heliyon, 10, e31705. doi:10.1016/j.heliyon.2024.e31705. https://pubmed.ncbi.nlm.nih.gov/38845982/
3. Palmowski, Andriko, Strehl, Cindy, Pfeiffenberger, Moritz, Gaber, Timo, Buttgereit, Frank. 2023. Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis. In Clinical rheumatology, 43, 511-519. doi:10.1007/s10067-023-06814-2. https://pubmed.ncbi.nlm.nih.gov/37978145/
4. Levin, Avi, Minis, Adi, Lalazar, Gadi, Rodriguez, Jose, Steller, Hermann. 2018. PSMD5 Inactivation Promotes 26S Proteasome Assembly during Colorectal Tumor Progression. In Cancer research, 78, 3458-3468. doi:10.1158/0008-5472.CAN-17-2296. https://pubmed.ncbi.nlm.nih.gov/29716915/
5. Li, Yaquan, Liu, Xuemeng, Zhao, Feihu, Huang, Bin, Chen, Anjing. 2023. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma. In CNS neuroscience & therapeutics, 30, e14366. doi:10.1111/cns.14366. https://pubmed.ncbi.nlm.nih.gov/37485655/
智鼠故事 
